Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer
J.W. Simons(Johns Hopkins University), Fray F. Marshall(Johns Hopkins University), Karen M. Hauda(Johns Hopkins University), C. Weber(Johns Hopkins University), William G. Nelson(Johns Hopkins University), L. Cohen, S Clift, Elizabeth M. Jaffee(Bloomberg (United States)), Drew M. Pardoll(Bloomberg (United States)), Kristin M. Leiferman(University of Utah), Lisa A. Beck(University of Rochester Medicine), Steven Piantadosi(Brigham and Women's Hospital), Richard Mulligan(Harvard University), Albert H. Owens(Johns Hopkins University), A Lazenby(University of Alabama at Birmingham), Hy Levitsky(Johns Hopkins University), Michael A. Carducci(Sidney Kimmel Comprehensive Cancer Center), Glen Dranoff(Dana-Farber Cancer Institute), C. C. Finn(Johns Hopkins University)
Cited by 414
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k